Legal & General Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5K | Sell |
18,395
-1,563
| -8% | -$3.61K | ﹤0.01% | 2744 |
|
|
2025
Q1 | $27.7K | Sell |
19,958
-60
| -0.3% | -$83 | ﹤0.01% | 2833 |
|
|
2024
Q4 | $34.6K | Hold |
20,018
| – | – | ﹤0.01% | 2852 |
|
|
2024
Q3 | $40.2K | Buy |
20,018
+2,093
| +12% | +$4.21K | ﹤0.01% | 2828 |
|
|
2024
Q2 | $40.2K | Buy |
+17,925
| New | +$40.2K | ﹤0.01% | 2824 |
|
|
2022
Q2 | – | Sell |
-16,100
| Closed | -$104K | – | 3656 |
|
|
2022
Q1 | $104K | Hold |
16,100
| – | – | ﹤0.01% | 2852 |
|
|
2021
Q4 | $187K | Buy |
16,100
+8,993
| +127% | +$104K | ﹤0.01% | 2747 |
|
|
2021
Q3 | $132K | Buy |
7,107
+3,358
| +90% | +$62.4K | ﹤0.01% | 2793 |
|
|
2021
Q2 | $80K | Buy |
3,749
+2,835
| +310% | +$60.5K | ﹤0.01% | 2806 |
|
|
2021
Q1 | $18K | Hold |
914
| – | – | ﹤0.01% | 3178 |
|
|
2020
Q4 | $24K | Buy |
914
+14
| +2% | +$368 | ﹤0.01% | 3024 |
|
|
2020
Q3 | $20K | Buy |
+900
| New | +$20K | ﹤0.01% | 2973 |
|